India’s pandemic preparedness helps implement robust strategy to manage Mpox outbreak: Dr Gowri Kulkarni

India’s pandemic preparedness helps implement robust strategy to manage Mpox outbreak: Dr Gowri Kulkarni


Posted on September 25, 2024 Updated on September 22, 2024

India’s healthcare system has implemented a robust strategy to handle potential Mpox outbreaks. With 35 equipped laboratories nationwide, enhanced surveillance measures, and a comprehensive plan from the National Centre for Disease Control, the country is prepared for early detection and response. State-level authorities are actively raising awareness and establishing isolation facilities.

According to Dr Gowri Kulkarni, head of medical operations, MediBuddy, this strategic blend of readiness, precise strain identification, and proactive public health measures ensure that India’s healthcare system is well-positioned to manage any potential Mpox outbreak effectively.

While maintaining vigilance, especially at entry points with targeted passenger screening, health officials assess the risk of a large-scale outbreak as low. Importantly, India’s capability to identify specific viral strains—such as differentiating between ‘clade 2,’ seen in recent cases, and the more concerning ‘clade 1’—enables a focused and appropriate response, she added.

The country’s approach to Mpox preparedness reflects a strategic evolution in public health management, building on lessons from Covid-19. The rapid establishment of specialised laboratories across the country demonstrates a commitment to accessible, rapid testing at the grassroots level. This network, coupled with a comprehensive surveillance strategy, empowers local health authorities to act swiftly and decisively. By prioritising early detection and community-level response, India has created a more resilient and adaptable health infrastructure this time. This proactive stance not only positions the country well for managing potential Mpox cases but also strengthens its overall capacity to address future health challenges with greater confidence and efficiency, Dr Gowri told Pharmabiz.

The pandemic preparedness has significantly improved since Covid-19, with advancements extending globally. Testing capacities have expanded dramatically, allowing for rapid scaling and diverse testing methods. Surveillance strategies have become more sophisticated. Healthcare systems have bolstered their resilience, while international cooperation has strengthened, improving early warning systems and information sharing, she noted.

Public health communication strategies have evolved to combat misinformation more effectively. Containment strategies have evolved to be more nuanced and effective. Contact tracing methodologies have been refined, often aided by digital technologies. These collective advancements position the world to respond to future pandemic threats with greater speed, coordination, and effectiveness.

Emphasis is on education, hygiene, and monitoring for milder symptoms. Individuals are advised to practise strict hygiene, avoid exposure, and seek prompt medical care if symptomatic, given potential complications from underlying conditions. Immunocompromised people face the highest risk, and require enhanced precautions. They may require more aggressive treatment if infected. All vulnerable groups will need to maintain close contact with healthcare providers for personalised advice. These guidelines stress the importance of prevention, early detection, and appropriate medical intervention, adapted to each group’s specific needs and risk factors. It is crucial to be vigilant about symptoms and seek early advice. Travellers with a history of exposure or symptoms should quarantine for 21 days to help prevent the spread and protect public health, said Dr Gowri.

Source : 1